Compugen (CGEN) Property, Plant & Equipment (Net) Growth (3y) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -14.40%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -9.89%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -0.31%
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -23.68%
Sep 30, 2025 -22.14%
Jun 30, 2025 -19.43%
Mar 31, 2025 -17.09%
Dec 31, 2024 -19.90%
Sep 30, 2024 -16.16%
Jun 30, 2024 -15.83%
Mar 31, 2024 -11.25%
Dec 31, 2023 -10.76%
Sep 30, 2023 -13.10%
Jun 30, 2023 -12.60%
Mar 31, 2023 -12.56%
Dec 31, 2022 -13.14%
Sep 30, 2022 -12.75%
Jun 30, 2022 -16.63%
Mar 31, 2022 -18.55%
Dec 31, 2021 -21.07%
Sep 30, 2021 -23.78%
Jun 30, 2021 -24.25%
Mar 31, 2021 -27.90%
Dec 31, 2020 -28.33%
Sep 30, 2020 -27.49%
Jun 30, 2020 -27.31%
Mar 31, 2020 -27.13%
Dec 31, 2019 -26.82%
Sep 30, 2019 -25.80%
Jun 30, 2019 -23.44%
Mar 31, 2019 -21.29%
Dec 31, 2018 -17.60%
Sep 30, 2018 10.12%
Jun 30, 2018 11.48%
Mar 31, 2018 16.49%
Dec 31, 2017 19.40%
Sep 30, 2017 27.95%
Jun 30, 2017 37.87%
Mar 31, 2017 52.12%
Dec 31, 2016 70.29%
Sep 30, 2016 74.43%
Jun 30, 2016 71.36%
Mar 31, 2016 74.75%
Dec 31, 2015 68.95%
Sep 30, 2015 36.95%
Jun 30, 2015 60.23%
Mar 31, 2015 77.81%
Dec 31, 2014 76.44%
Sep 30, 2014 64.47%
Jun 30, 2014 56.71%
Mar 31, 2014 42.21%
Dec 31, 2013 27.71%
Sep 30, 2013 22.22%
Jun 30, 2013 24.13%
Mar 31, 2013 19.78%
Dec 31, 2012 19.36%
Sep 30, 2012 13.92%
Jun 30, 2012 -6.63%
Mar 31, 2012 -20.79%